Breaking News on Global Pharmaceutical Technology & Manufacturing

Roche getting under the skin of biosimilar competition

25-Jul-2016 - Subcutaneous versions of its biologic blockbusters - including Mabthera and Herceptin - will help protect against biosimilar competition, says Roche.

Evonik to buy CDMO for drug delivery technologies

19-Jul-2016 - Evonik has bought Transferra Nanosciences to expand its injectable drug delivery technology offering.

MonoSol Rx licenses film tech to Kuraray-owned namesake for non-pharma uses

18-Jul-2016 - MonoSol Rx licenses delivery film tech to MonoSol LLC for non-pharma uses.

Pharmacy researchers work to improve drug delivery

14-Jul-2016 - Researchers suggest targeted nanosystem drug delivery could be the key to crossing gastrointestinal tract and blood-brain barriers – a prevailing issue with oral medications.

Corium Alzheimer's disease patch could be available by 2019

06-Jul-2016 - A transdermal patch formulation of the most commonly used Alzheimer's disease (AD) drug could be on the market in 2019 - two to three years earlier than expected.

Astellas to develop rice-based oral cholera vaccine

06-Jul-2016 - Japan's Astellas has agreed to carry out clinical trials of a vaccine for serious diarrhoeal diseases which does not need to be refrigerated or injected and is produced in transgenic rice plants.

J&J's insulin patch finally heading for launch

05-Jul-2016 - Johnson & Johnson has finally announced a launch schedule for its One Touch Via insulin patch - some four years after it was first approved in the US.

Silk rockets and 3D printing: Researchers looks to transform drug delivery

30-Jun-2016 - Engineers from the University of Sheffield have developed 3D-printed silk 'micro-rockets' they say could be used to improve drug delivery.

Magnetically controlled drug dissolves blood clots with fewer side effects

27-Jun-2016 - Researchers have developed a new magnetically controlled drug that can dissolve clots up to 4,000 times more efficiently than ordinary enzyme-based drugs.

Collegium's OxyContin rival is first drug using Deterx anti-abuse tech launched in US

21-Jun-2016 - Collegium Pharmaceutical has launched the first product formulated using its Deterx anti-abuse technology in the US.

Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

15-Jun-2016 - Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

Replicating DNA structures is key to faster gene therapy vector manufacturing says Touchlight

10-Jun-2016 - Replicating secondary structures in viral DNA could be key to developing to faster AAV vector production methods according to UK tech firm Touchlight.


Cobra and Touchlight aim to make AAV vector production faster and cheaper

07-Jun-2016 - Cobra Biologics has teamed up with Touchlight to test an AAV vector production platform they claim will make manufacturing gene therapies for trials cheaper and faster.

US FDA approved implant offers opioid addicts six-months continuous treatment

02-Jun-2016 - The US FDA has approved Probuphine, a subdermal buprenorphine treatment for opioid dependence using Titan Pharmaceuticals’ ProNeura drug delivery platform.

EU approves second indication for subcutaneous form of Roche's rituximab

01-Jun-2016 - Roche’s subcutaneous formulation of MabThera is about reducing the treatment burden for patients and not protecting it from impending biosimilar competition, the firm says.

Novo Nordisk and Sanofi diabetes combo drugs receive US recommendation

26-May-2016 - The US FDA has voted in favour of two combination type 2 diabetes drugs putting Novo Nordisk and Sanofi head-to-head in a crowded market.

Combination therapies key to curing cancer, says Pfizer

24-May-2016 - Combination therapies and collaboration will be key in curing cancer, according to Pfizer which has seen 'astounding progress' in its immuno-oncology partnership with Merck KGaA.

Albumedix tech key to Chinese efforts to develop once-a-week diabetes drug

23-May-2016 - Recombinant albumin supplier Albumedix will help Hebei Changshan Biochem Pharma develop a once-a-week diabetes treatment.

New technique creates 'nearly pure drug' for injection

19-May-2016 - Researchers have developed an “easy-to-adopt” process for removing excess additives from injectable drugs.

Glide begins solid dose, injectable acromegaly drug trial on birthday of most famous sufferer

19-May-2016 - A solid dose version of the acromegaly treatment octreotide developed by Glide Technologies has entered a proof-of-concept study.

Finished dosage formulations demand driving changes for CMOs

18-May-2016 - As “one of the fastest growing areas in pharma,” the demand for finished dosage formulations is having an impact on several aspects of the CMO industries.

Pfizer, Anacor enter into merger agreement

18-May-2016 - Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for approximately $5.2bn.

Biogen eyes Regenxbio delivery tech for candidate occular gene therapies

17-May-2016 - Biogen has licensed rights use a gene therapy delivery technology from developer Regenxbio.

Capsugel adds European micro-dosing capacity

16-May-2016 - Rumoured IPO-ready Capsugel has added micro-dose capabilities at its facility in Ploërmel, France citing its acquisition of Xcelience as the driver for the expansion.

Ferrer to add drug aerosol delivery tech through Alexza acquisition

11-May-2016 - Grupo Ferrer Internacional will acquire Alexza Pharmaceuticals for around $2m, adding the Staccato aerosol system to its drug delivery offerings.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...